Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study.
Chawla S, Blay JY, Rutkowski P, Le Cesne A, Reichardt P, Gelderblom H, Grimer RJ, Choy E, Skubitz K, Seeger L, Schuetze SM, Henshaw R, Dai T, Jandial D, Palmerini E.
Chawla S, et al. Among authors: henshaw r.
Lancet Oncol. 2019 Dec;20(12):1719-1729. doi: 10.1016/S1470-2045(19)30663-1. Epub 2019 Nov 6.
Lancet Oncol. 2019.
PMID: 31704134
Clinical Trial.